Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+T cells

被引:0
|
作者
Gomez Aleza, Clara [1 ]
Nguyen, Bastien [2 ]
Yoldi, Guillermo [1 ]
Ciscar, Marina [3 ]
Barranco, Alexandra [3 ]
Hernandez Jimenez, Enrique [1 ]
Maetens, Marion [2 ]
Salgado, Roberto [2 ]
Zafeiroglou, Maria [1 ]
Pellegrini, Pasquale [1 ]
Venet, David [2 ]
Garaud, Soizic [4 ]
Trinidad, Eva M. [1 ]
Benitez, Sandra [1 ]
Munoz, Purificacion [1 ]
Walzer, Thierry [8 ]
Planelles, Lourdes [9 ]
Penninger, Josef [10 ,11 ]
Azim, Hatem A., Jr. [5 ,12 ]
Loi, Sherene [6 ,7 ]
Piccart, Martine
Sotiriou, Christos [2 ]
Gonzalez Suarez, Eva [3 ]
机构
[1] IDIBELL, Bellvitge Biomed Res Inst, Oncobell, Barcelona, Spain
[2] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab J C Heuson, Brussels, Belgium
[3] Spanish Natl Canc Res Ctr CNIO, Mol Oncol, Madrid, Spain
[4] Univ Libre Bruxelles, Inst Jules Bordet, Mol Immunol Unit, Brussels, Belgium
[5] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium
[6] Walter & Eliza Hall Inst Med Res, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[7] Royal Melbourne Hosp, Melbourne, Vic, Australia
[8] Univ Claude Bernard, Ctr Int Rech Infectiol, CIRI, Inserm U1111,CNRS, Lyon, France
[9] Parc Cientif Univ, BiOncotech Therapeut, Valencia, Spain
[10] Univ British Columbia, Inst Life Sci, Vancouver, BC, Canada
[11] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, Vienna, Austria
[12] Amer Univ Beirut, Dept Med, Div Hematol Oncol, Beirut, Lebanon
关键词
Animal models; cancer immunology; immunotherapy; in vivo tumor models; molecular immunology;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-0736
引用
收藏
页码:239 / 239
页数:1
相关论文
共 50 条
  • [1] Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+T cells
    Gomez-Aleza, Clara
    Nguyen, Bastien
    Yoldi, Guillermo
    Ciscar, Marina
    Barranco, Alexandra
    Hernandez-Jimenez, Enrique
    Maetens, Marion
    Salgado, Roberto
    Zafeiroglou, Maria
    Pellegrini, Pasquale
    Venet, David
    Garaud, Soizic
    Trinidad, Eva M.
    Benitez, Sandra
    Vuylsteke, Peter
    Polastro, Laura
    Wildiers, Hans
    Simon, Philippe
    Lindeman, Geoffrey
    Larsimont, Denis
    Van den Eynden, Gert
    Velghe, Chloe
    Rothe, Francoise
    Willard-Gallo, Karen
    Michiels, Stefan
    Munoz, Purificacion
    Walzer, Thierry
    Planelles, Lourdes
    Penninger, Josef
    Azim, Hatem A., Jr.
    Loi, Sherene
    Piccart, Martine
    Sotiriou, Christos
    Gonzalez-Suarez, Eva
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [2] Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells
    Clara Gómez-Aleza
    Bastien Nguyen
    Guillermo Yoldi
    Marina Ciscar
    Alexandra Barranco
    Enrique Hernández-Jiménez
    Marion Maetens
    Roberto Salgado
    Maria Zafeiroglou
    Pasquale Pellegrini
    David Venet
    Soizic Garaud
    Eva M. Trinidad
    Sandra Benítez
    Peter Vuylsteke
    Laura Polastro
    Hans Wildiers
    Philippe Simon
    Geoffrey Lindeman
    Denis Larsimont
    Gert Van den Eynden
    Chloé Velghe
    Françoise Rothé
    Karen Willard-Gallo
    Stefan Michiels
    Purificación Muñoz
    Thierry Walzer
    Lourdes Planelles
    Josef Penninger
    Hatem A. Azim
    Sherene Loi
    Martine Piccart
    Christos Sotiriou
    Eva González-Suárez
    Nature Communications, 11
  • [3] CD8+T cell precursor frequency determines the quality of the anti-tumor immune response
    Rizzuto, Gabrielle A.
    Merghoub, Taha
    Hirschhorn-Cymerman, Daniel
    Liu, Cailian
    Leskohin, Alexander M.
    Zhong, Hong
    Panageas, Katherine S.
    Perales, Miguel-Angel
    Altan-Bonnet, Gregoire
    Wolchok, Jedd D.
    Houghton, Alan N.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [4] Unraveling the anti-tumor partnership of CD169+macrophages and CD8+T cells in a preclinical breast cancer model
    Couturier, Nicole
    Boutet, Marie
    Nishitani, Kenta
    Guo, Wenjun
    Lauvau, Gregoire
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Inhibition of PYK2 enhances the anti-tumor effect of CD8+T cells in melanoma
    Mizuno, Y.
    Umemura, M.
    Suzuki, F.
    Hayashi, C.
    Nagasako, A.
    Ishikawa, S.
    Yamaguchi, Y.
    Ishikawa, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S106 - S106
  • [6] Radiotherapy enhances newly infiltrating CD8+T cells into tumor tissue to increase intratumor CD8+T cells and exert an anti-tumor effects
    Yamashita, Kimihiro
    Fukuoka, Eiji
    Sugita, Yutaka
    Arimoto, Akira
    Watanabe, Akihiro
    Takiguchi, Gousuke
    Urakawa, Naoki
    Hasegawa, Hiroshi
    Yamamoto, Masashi
    Kanaji, Shingo
    Matsuda, Yoshiko
    Matsuda, Takeru
    Oshikiri, Taro
    Nakamura, Tetsu
    Suzuki, Satoshi
    Kakeji, Yoshihiro
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Initial IL7R signaling regulate the induction of effector CD8+T cells and subsequent anti-tumor immune response in lymphopenic host
    Suzuki, Toshihiro
    Kishimoto, Hidehiro
    Abe, Ryo
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [8] Targeting cathepsin B in the pancreatic stellate cells stimulates CD8+T cell dependent anti-tumor immune response.
    Garg, Bharti
    Jain, Tejeshwar
    Vaish, Utpreksha
    Dudeja, Vikas
    CANCER RESEARCH, 2021, 81 (22) : 74 - 75
  • [9] Lactate increases stemness of CD8+T cells to augment anti-tumor immunity
    Feng, Qiang
    Liu, Zhida
    Yu, Xuexin
    Huang, Tongyi
    Chen, Jiahui
    Wang, Jian
    Wilhelm, Jonathan
    Li, Suxin
    Song, Jiwon
    Li, Wei
    Sun, Zhichen
    Sumer, Baran D.
    Li, Bo
    Fu, Yang-Xin
    Gao, Jinming
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [10] Age-related decline in anti-tumor activity of CD8+T cells
    Xiao, Yichuan
    Pei, Siyu
    Deng, Xiuyu
    Yang, Ruirui
    Wang, Hui
    Wang, Xueqing
    Luo, Qingquan
    Zheng, Mingyue
    CANCER SCIENCE, 2025, 116 : 67 - 67